Prospective study of the efficacy of imeglimin and metformin against insulin secretion and resistance in patients with type 2 diabetes
Latest Information Update: 17 Feb 2025
At a glance
- Drugs Imeglimin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
Most Recent Events
- 01 Feb 2025 Results assessing to compare the effects of imeglimin and metformin on incretin secretion (GLP-1 and GIP) and glucose control in patients with type 2 diabetes were published in the Diabetes, Obesity and Metabolism.
- 27 Nov 2024 New trial record